ITMI20042413A1 - Processo per la preparazione di galantamina bromidrato - Google Patents

Processo per la preparazione di galantamina bromidrato

Info

Publication number
ITMI20042413A1
ITMI20042413A1 IT002413A ITMI20042413A ITMI20042413A1 IT MI20042413 A1 ITMI20042413 A1 IT MI20042413A1 IT 002413 A IT002413 A IT 002413A IT MI20042413 A ITMI20042413 A IT MI20042413A IT MI20042413 A1 ITMI20042413 A1 IT MI20042413A1
Authority
IT
Italy
Prior art keywords
galanthamine
preparation
butyl
hydrobromide
bromidrate
Prior art date
Application number
IT002413A
Other languages
English (en)
Inventor
Bruno Gabetta
Enrico Mercalli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT002413A priority Critical patent/ITMI20042413A1/it
Publication of ITMI20042413A1 publication Critical patent/ITMI20042413A1/it
Priority to PCT/EP2005/012521 priority patent/WO2006063666A1/en
Priority to JP2007545863A priority patent/JP5166878B2/ja
Priority to RU2007122353/04A priority patent/RU2387656C2/ru
Priority to ES05808194T priority patent/ES2330127T3/es
Priority to DE602005016308T priority patent/DE602005016308D1/de
Priority to KR1020077013259A priority patent/KR101291446B1/ko
Priority to PL05808194T priority patent/PL1861105T3/pl
Priority to PT05808194T priority patent/PT1861105E/pt
Priority to SI200530788T priority patent/SI1861105T1/sl
Priority to CN2005800429800A priority patent/CN101080231B/zh
Priority to AU2005315960A priority patent/AU2005315960B2/en
Priority to EP05808194A priority patent/EP1861105B1/en
Priority to AT05808194T priority patent/ATE440607T1/de
Priority to CA2592288A priority patent/CA2592288C/en
Priority to DK05808194T priority patent/DK1861105T3/da
Priority to US11/793,097 priority patent/US8013151B2/en
Priority to IL183933A priority patent/IL183933A0/en
Priority to NO20073053A priority patent/NO338724B1/no
Priority to HK08102754.4A priority patent/HK1113306A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IT002413A 2004-12-17 2004-12-17 Processo per la preparazione di galantamina bromidrato ITMI20042413A1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT002413A ITMI20042413A1 (it) 2004-12-17 2004-12-17 Processo per la preparazione di galantamina bromidrato
US11/793,097 US8013151B2 (en) 2004-12-17 2005-11-23 Process for the preparation of galanthamine hydrobromide
PT05808194T PT1861105E (pt) 2004-12-17 2005-11-23 Processo para a preparação de bromidrato de galantamina
CN2005800429800A CN101080231B (zh) 2004-12-17 2005-11-23 氢溴酸加兰他敏的制备方法
RU2007122353/04A RU2387656C2 (ru) 2004-12-17 2005-11-23 Способ получения гидробромида галантамина
ES05808194T ES2330127T3 (es) 2004-12-17 2005-11-23 Procedimiento de preparacion de bromhidrato de galantamina.
DE602005016308T DE602005016308D1 (de) 2004-12-17 2005-11-23 Verfahren zur herstellung von galanthaminhydrobromid
KR1020077013259A KR101291446B1 (ko) 2004-12-17 2005-11-23 갈란타민 하이드로브로마이드의 제조 방법
PL05808194T PL1861105T3 (pl) 2004-12-17 2005-11-23 Sposób wytwarzania bromowodorku galantaminy
PCT/EP2005/012521 WO2006063666A1 (en) 2004-12-17 2005-11-23 Process for the preparation of galanthamine hydrobromide
SI200530788T SI1861105T1 (sl) 2004-12-17 2005-11-23 Postopek priprave galantamin hidrobromida
JP2007545863A JP5166878B2 (ja) 2004-12-17 2005-11-23 臭化水素酸ガランタミンの製造方法
AU2005315960A AU2005315960B2 (en) 2004-12-17 2005-11-23 Process for the preparation of galanthamine hydrobromide
EP05808194A EP1861105B1 (en) 2004-12-17 2005-11-23 Process for the preparation of galanthamine hydrobromide
AT05808194T ATE440607T1 (de) 2004-12-17 2005-11-23 Verfahren zur herstellung von galanthaminhydrobromid
CA2592288A CA2592288C (en) 2004-12-17 2005-11-23 Process for the preparation of galanthamine hydrobromide
DK05808194T DK1861105T3 (da) 2004-12-17 2005-11-23 Fremgangsmåde til fremstilling af galanthamin-hydrobromid
IL183933A IL183933A0 (en) 2004-12-17 2007-06-14 Process for the preparation fo galanthamine hydrobromide
NO20073053A NO338724B1 (no) 2004-12-17 2007-06-15 Fremgangsmåte for fremstilling av galantaminhydrobromid
HK08102754.4A HK1113306A1 (en) 2004-12-17 2008-03-10 Process for the preparation of galanthamine hydrobromide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002413A ITMI20042413A1 (it) 2004-12-17 2004-12-17 Processo per la preparazione di galantamina bromidrato

Publications (1)

Publication Number Publication Date
ITMI20042413A1 true ITMI20042413A1 (it) 2005-03-17

Family

ID=35784718

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002413A ITMI20042413A1 (it) 2004-12-17 2004-12-17 Processo per la preparazione di galantamina bromidrato

Country Status (20)

Country Link
US (1) US8013151B2 (it)
EP (1) EP1861105B1 (it)
JP (1) JP5166878B2 (it)
KR (1) KR101291446B1 (it)
CN (1) CN101080231B (it)
AT (1) ATE440607T1 (it)
AU (1) AU2005315960B2 (it)
CA (1) CA2592288C (it)
DE (1) DE602005016308D1 (it)
DK (1) DK1861105T3 (it)
ES (1) ES2330127T3 (it)
HK (1) HK1113306A1 (it)
IL (1) IL183933A0 (it)
IT (1) ITMI20042413A1 (it)
NO (1) NO338724B1 (it)
PL (1) PL1861105T3 (it)
PT (1) PT1861105E (it)
RU (1) RU2387656C2 (it)
SI (1) SI1861105T1 (it)
WO (1) WO2006063666A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT507256B1 (de) * 2008-09-04 2010-10-15 Sanochemia Pharmazeutika Ag Verwendung von galanthaminiumbromid zur herstellung von ophthalmischen formulierungen zur glaukombehandlung
US8247405B2 (en) * 2008-12-10 2012-08-21 Conopco, Inc. Skin lightening compositions with acetylcholinesterase inhibitors
CN101787028B (zh) * 2010-01-12 2012-01-04 恩施清江生物工程有限公司 一种从忽地笑中提取加兰他敏的方法
BG110754A (bg) 2010-09-20 2012-03-30 "Ар енд ДИ" ООД Метод и инсталация за екстракция на растителни суровини
BG66818B1 (bg) * 2013-03-07 2019-01-31 Berbee Beheer B. V. Състав на екстракт от hippeastrum papilio за производство на лекарствени средства и хранителни добавки
CN104177368B (zh) * 2014-05-27 2016-06-08 天津梅花医药有限公司 一种氢溴酸加兰他敏化合物、制备方法及其药物组合物
CN103980284B (zh) * 2014-05-30 2016-03-09 天津梅花医药有限公司 一种氢溴酸加兰他敏化合物及其制备方法
CN107462656A (zh) * 2017-07-04 2017-12-12 上海市农业科学院 一种快速检测石蒜科植物中加兰他敏含量的方法
BG67337B1 (bg) 2018-05-23 2021-06-15 Софарма Ад Метод за получаване на пречистен галантамин хидробромид

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB942200A (en) 1959-03-02 1963-11-20 Chimiko Pharmazevtitschen Zd A method of obtaining galanthamine hydrobromide
GB938767A (en) 1961-12-13 1963-10-09 Vni Chimico Pharmatsevtichesky The preparation of galanthamine from the amaryllidaceae and its separation from associated alkaloids
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
CN1261434C (zh) * 2003-07-28 2006-06-28 浙江一新制药股份有限公司 从石蒜粗提物中分离高纯度加兰他敏的方法
DE102006033591B4 (de) 2006-07-18 2008-10-16 Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. Verfahren zur Stabilisierung der Spinnlösung bei der Herstellung von cellulosischen Verbundformkörpern

Also Published As

Publication number Publication date
US8013151B2 (en) 2011-09-06
CA2592288A1 (en) 2006-06-22
NO338724B1 (no) 2016-10-10
HK1113306A1 (en) 2008-10-03
SI1861105T1 (sl) 2009-12-31
DE602005016308D1 (de) 2009-10-08
US20090043092A1 (en) 2009-02-12
KR101291446B1 (ko) 2013-07-30
ATE440607T1 (de) 2009-09-15
PL1861105T3 (pl) 2010-02-26
PT1861105E (pt) 2009-10-22
JP5166878B2 (ja) 2013-03-21
NO20073053L (no) 2007-06-15
CA2592288C (en) 2014-05-06
CN101080231A (zh) 2007-11-28
WO2006063666A1 (en) 2006-06-22
ES2330127T3 (es) 2009-12-04
EP1861105A1 (en) 2007-12-05
RU2007122353A (ru) 2008-12-20
AU2005315960B2 (en) 2012-01-12
CN101080231B (zh) 2010-11-17
EP1861105B1 (en) 2009-08-26
DK1861105T3 (da) 2009-11-16
RU2387656C2 (ru) 2010-04-27
AU2005315960A1 (en) 2006-06-22
JP2008524125A (ja) 2008-07-10
IL183933A0 (en) 2007-10-31
KR20070095897A (ko) 2007-10-01

Similar Documents

Publication Publication Date Title
HK1113306A1 (en) Process for the preparation of galanthamine hydrobromide
WO2005037825A3 (en) Protein kinase inhibitors
TW200633979A (en) Method
TW200716541A (en) The preparation and use of compounds as protease inhibitors
FI1610780T4 (fi) Sykliset proteiinityrosiinikinaasi-inhibiittorit
HUP0102084A2 (hu) Kinolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
WO2004058679A3 (en) Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
UA93044C2 (en) urn:schemas-microsoft-com:office:smarttagsCRYSTALFORM OF ASENAPINE MALEATE
PE20110834A1 (es) DERIVADOS DE PIRROL[3,4-d]PIRIMIDINA COMO INHIBIDORES DE FOSFODIESTERASA 1 (PDE1)
MY139797A (en) (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate
CO6170356A2 (es) Derivados de piridazina
GEP20115243B (en) Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds
DE602004018630D1 (en) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
EA200700139A1 (ru) Способ отделения и очистки цезия-131 от карбоната бария
TN2010000173A1 (fr) Antagonistes de cgrp
MY133527A (en) Isoquinoline derivatives
ATE518835T1 (de) Kristallform einer chinolinverbindung und verfahren zu deren herstellung
DE502005004950D1 (de) Verfahren zur herstellung einer lösung von reinem triethylendiamin (teda)
DK1501859T3 (da) 17 alfa-fluoralkyl- 11 beta-benzaldoxim-steroider, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse steroider samt deres anvendelse til fremstilling af lægemidler
WO2004058683A3 (en) Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
RS98603A (en) Lactone formulations and method of use
ATE457304T1 (de) Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle
UA93489C2 (ru) Гетероциклические соединения kak антагонисты ccr2b
TH77099A (th) สารประกอบต้านไวรัสชนิดเฮเทอโรไซคลิก
ATE509932T1 (de) Polymorphe form von 6-(4-chlorphenyl)-2,2-